Efficacy and Safety of Thread Embedding Acupuncture in Treating Gastroesophageal Reflux Disease
NCT05353933 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66
Last updated 2022-07-28
Summary
Gastroesophageal reflux disease is a very common disease nowadays. Proton-pump inhibitors (PPIs) are the first-line treatment for this disease. However, the effectiveness of treatment with PPIs is still limited. Acupuncture has been shown to be effective in treating this condition. Another treatment method is thread embedding acupuncture therapy, which is a method of burying threads into acupoints to create a more lasting stimulation than traditional acupuncture.
This study will evaluate the efficacy and safety of the combination of thread embedding acupuncture and standard dose pantoprazole compared with standard dose pantoprazole as monotherapy in adults.
Conditions
- Gastroesophageal Reflux
Interventions
- OTHER
-
Thread embedding acupuncture
Thread embedding acupuncture (TEA) that use chromic catgut thread with 3/0 size with 1 centimeter long for each acupoint (TRUSTIGUT® (C), CPT Sutures Co., Ltd, Ho Chi Minh, Vietnam). Every 2 weeks in 4 weeks (twice), 13 acupoints will be embedded including Xiawan (CV-10), Zhongwan (CV-12), Shangwan (CV-13) and Zusanli (ST-36), Neiguan (PC-6), Geshu (BL-17), Ganshu (BL-18), Pishu (BL-20) in both sides of the body.
- DRUG
-
Pantoprazole 40mg
Oral pantoprazole 40 mg capsules (Pantostad 40 CAP, Stellapharm J.V. Co., Ltd, Binh Duong, Vietnam) thirty minutes to one hour before the first meal once daily for 4 weeks.
Sponsors & Collaborators
-
University of Medicine and Pharmacy at Ho Chi Minh City
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-05-04
- Primary Completion
- 2022-07-20
- Completion
- 2022-07-20
Countries
- Vietnam
Study Locations
More Related Trials
-
Endoscopic Cardial Constriction Ligation (ECCL) for Refractory GERD Using a Disposable Endoscope
NCT07176221 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Potential Therapeutic Effect of Melatonin in Gastro-Esophageal Reflux Disease
NCT00915616 ·Status: WITHDRAWN ·Phase: PHASE3
-
Hyaluronic Acid in Patients With Gastroesophageal Reflux Disease
NCT05561179 ·Status: UNKNOWN ·Phase: NA
-
The Primary Symptoms of GERD(Gastroesophageal Reflux Disease) in Chinese Outpatients in Gastroenterology Department
NCT02506634 ·Status: COMPLETED
-
Radiofrequency Energy Delivery for Gastroesophageal Reflux Disease
NCT03223116 ·Status: UNKNOWN ·Phase: NA
-
Assessment on Effects of Tongjiang Granule in Treating Nonerosive Reflux Disease Overlapping Epigastric Pain Syndrome
NCT05312463 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study
NCT00235677 ·Status: COMPLETED ·Phase: PHASE3
-
Outcomes for Patients With Gastro-Esophageal Reflux Disease
NCT03824548 ·Status: UNKNOWN
-
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
NCT01472939 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Gut-Brain Neuromodulators in the Treatment of Gastroesophageal Reflux Disease
NCT06945237 ·Status: COMPLETED ·Phase: NA
-
Anti-Reflux Endoscopic Therapy Using Argon Plasma Coagulation (AREA) in Gastroesophageal Reflux Disease (GERD) Patients: A Single Center, Randomized, Sham, Controlled Trial (The AREA Study)
NCT06641375 ·Status: RECRUITING ·Phase: NA
-
Effective Mechanisms of Wu-Chu-Yu Tang on Gastroesophageal Disorder
NCT04118647 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD)
NCT00561730 ·Status: COMPLETED
-
A Novel Endoloop Pre-test to Treat Gastroesophageal Reflux
NCT05192538 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD)
NCT01161602 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339)
NCT00163306 ·Status: COMPLETED ·Phase: PHASE3
-
the Efficency and Safety of Stretta in GERD
NCT03574831 ·Status: UNKNOWN
-
Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders
NCT00830115 ·Status: COMPLETED
-
Manual Therapy and Gastroesophageal Reflux Disease in Patients With Hiatal Hernia
NCT05283447 ·Status: COMPLETED ·Phase: NA
-
Role of Mosapride in Patients With Gastroesophageal Reflux Disease
NCT00729339 ·Status: COMPLETED ·Phase: PHASE4
-
Diagnostic Yield of Post PRandial Esophageal High Resolution Impedance Manometry in Patients With Gastro-Esophageal Reflux Disease Symptoms Resistant to Proton Pump Inhibitor Therapy
NCT03596476 ·Status: RECRUITING ·Phase: NA
-
Response Surface Pathway Design With Two Interventional- and One Response Variable in Estimating Minimum Efficacy Dose
NCT03568825 ·Status: COMPLETED ·Phase: NA
-
Gastroesophageal Reflux Disease Diagnostic Trial
NCT06504134 ·Status: NOT_YET_RECRUITING
-
Do Acid Sensing Ion Channels Contribute to Heartburn?
NCT01095133 ·Status: COMPLETED ·Phase: PHASE1
-
Anti-reflux Mucosectomy (ARMS) is a Useful Therapy for Refractory Gastroesophageal Reflux Disease (RGERD)
NCT03259191 ·Status: UNKNOWN ·Phase: NA